Cargando…
Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1′-CN-4-aza-7,9-dideazaadenosine C-nucleoside
Autores principales: | Zhou, Qifan, Yang, Sidi, Cao, Liu, Yang, Yang, Xu, Tiefeng, Chen, Qishu, Lu, Hongzhou, Li, Yingjun, Guo, Deyin, Zhang, Xumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835026/ https://www.ncbi.nlm.nih.gov/pubmed/36635259 http://dx.doi.org/10.1038/s41392-023-01310-0 |
Ejemplares similares
-
Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides
por: Cho, Aesop, et al.
Publicado: (2012) -
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants
por: Cao, Liu, et al.
Publicado: (2022) -
Synthesis of deuterated S-217622 (Ensitrelvir) with antiviral activity against coronaviruses including SARS-CoV-2
por: Yang, Yujian, et al.
Publicado: (2023) -
Nonsteroidal anti-inflammatory drugs (NSAIDs) and nucleotide analog GS-441524 conjugates with potent in vivo efficacy against coronaviruses
por: Zhou, Qifan, et al.
Publicado: (2023) -
trans-4-(Phenoxymethyl)cyclohexanecarboxylic acid
por: Yang, Jun, et al.
Publicado: (2008)